Navigation Links
CryoCath announces 2007 fourth quarter and fiscal year end financial results
Date:12/17/2007

t has started to show its explosive growth potential and has become the largest driver of our growth.

We are also confident with the progress in our pivotal trial in the US. STOP AF continues to be the fastest enrolling trial in this space and is on track to support a late 2009 US Arctic Front approval. Our confidence in the blockbuster potential of Arctic Front is strengthened continuously based on the solid clinical performance and enthusiastic feedback from both our European customers as well as our US investigators. We feel that in 2007 we created the foundation needed to allow us to bring our Arctic Front breakthrough therapy to millions of Paroxysmal AFib patients and create a significant and profitable business."

FY 2007

For the 12-month period ending September 30, 2007, sales increased 3.4% to reach $39.7 million compared to $38.4 million in fiscal 2006. US disposable EP product sales grew by 2.6% to $12.3 million, whereas outside US disposable revenue, driven by the success of Arctic Front, grew by 17.6% to 8.0 million. Total EP growth in the US was 11.1% to $18.3 million and outside US growth was 20.1% to $10.7 million.

Gross margins in fiscal 2007 were $23.5 million or 59.2% of sales, versus $20.6 million or 53.6% of sales in 2006. This increase in margins is a result of improved focus on the product supply process and the corresponding increase in output and yields, and the increase in sales of our higher margin new generation of products. Excluding the impact of the revenue accrual for returned goods included in the Q4 FY2007 results, but not in FY2006, gross margin for the year would have increased by 0.3% to 59.5%.

Total expenses in fiscal 2007 were $53.5 million, up 4.2% from $51.3 million in fiscal 2006.

Sales and marketing expenses in fiscal 2007 totaled $24.7 million versus $27.4 million for the same period a year ago. This decrease is based on a reduced head count and reduced commissions and other variabl
'/>"/>

SOURCE CryoCath Technologies Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. CryoCath files patent infringement lawsuit
2. CryoCath to present at CIBC Healthcare Conference
3. CryoCath to present at Piper Jaffray and BMO Healthcare conferences
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... a few extra cups of coffee each month might ... known as primary sclerosing cholangitis (PSC), a new study ... Minn., found that drinking coffee was associated with a ... to cirrhosis of the liver, liver failure and biliary ... relationship. "While rare, PSC has extremely detrimental ...
(Date:5/18/2013)... a May 14, 2013 article entitled “Angelina Jolie Reveals ... Fox News reported the movie star had opted to ... gene that doctors estimated gave her an 87 percent ... of ovarian cancer (go to: goo.gl/5JHBP). Ms. Jolie’s personal ... blog post entitled “A Patient’s Journey: Angelina Jolie” that ...
(Date:5/18/2013)... May 18, 2013 The Communities of ... special places we call home. These are the townships, villages ... are the locations where the people are friendly and neighbors ... viewers off the highways and shares the best in both ... nations with an American sports and film celebrity. It airs ...
(Date:5/18/2013)... Washington DC (PRWEB) May 18, 2013 Family ... Best" designation for excellence by Follow Media Consulting, Inc. in ... award signifies the continued commitment and dedication of the areas ... lifestyle. , No one knows parenting better than Brenda Hyde, ... goal is to help parents know about the vast resources ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 The “Sleep ... Pulse Oximeters, CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, ... Forecast to 2017” analyzes and studies the major market ... and Rest of the World. , Browse , ... 16 Figures , 318 ...
Breaking Medicine News(10 mins):Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:Summer Camps in DC "Best of the Best" Awarded to Family Magazine of Washington DC for Excellence by Follow Media Consulting, Inc. 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3
... by aiding in senior health and ... ... in market research for the health insurance industry, today,announced the release of ... and over population. SrHRA provides,proven health risk stratification measures based on self-reported,information ...
... ... benefits plans, COLUMBIA, S.C., Jan. 9 One of ... and a clearer message.,Colonial Life & Accident Insurance Company today ... who the company is and what it,does., (Logo: ...
... Expected results include higher quality care, increased ... Group Health Incorporated (GHI) and,Health Plan of New York ... first of its kind in New York, that will provide ... to become Medical,Home Practices. GHI and HIP see this as ...
... Diego, January 8, 2008 ?Eating out instead of cooking ... the American diet. Americans face a large variety of ... out. Do the choices of available restaurants matter ... the February 2008 issue of the American Journal of ...
... could improve understanding of irritable bowel syndrome and lead ... News) -- Women with irritable bowel syndrome anticipate and ... new study suggests. , The University of California, ... effectively switch off a pain modulation mechanism in the ...
... Reduce Stiffness for Better Health with,Innovative ,Sleep and ... FORT LAUDERDALE, Fla., Jan. 9 Contour ... people implement an,ergonomic makeover into their life for ... well being. By aligning the body, relieving,pressure points ...
Cached Medicine News:Health News:DSS Research Announces Senior Health Risk Assessment Tool 2Health News:New Colonial Life Brand Clarifies Company's Strengths 2Health News:New Colonial Life Brand Clarifies Company's Strengths 3Health News:GHI and HIP Launch Pilot Medical Home Network Project with Support from Commonwealth Fund 2Health News:GHI and HIP Launch Pilot Medical Home Network Project with Support from Commonwealth Fund 3Health News:Eating out can have both positive and negative impact on obesity 2Health News:Women With IBS Unable to Switch Off Pain Response 2Health News:Renew, Relax & Align the Body with an Ergonomic Makeover 2Health News:Renew, Relax & Align the Body with an Ergonomic Makeover 3
(Date:5/16/2013)... NORTH CHICAGO, Ill. and MECHELEN, ... NV (Euronext: GLPG) and AbbVie (NYSE: ABBV ... development collaboration to include Crohn,s disease.  Galapagos will fund ... which is designed to facilitate rapid progression into Phase ... Q2 2015, AbbVie will pay Galapagos $50 million.  The ...
(Date:5/16/2013)... and SYDNEY , May 16, ... - ASX: HIN), a leading innovator of less invasive, miniaturized ... heart failure, today announced that CEO Doug Godshall ... Global Healthcare Conference at 11:00 a.m. EDT on Monday, May ... at the Sheraton New York Hotel. A live ...
(Date:5/16/2013)... JACKSONVILLE, Florida , May 16, 2013 ... private practice in the U.S. to access the widely-used ... just a PC and Internet connection to get started. ... pre-operative planning software for over 10 years, is dedicated ... to template with digital x-ray images, when printed film ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2
... The ERATO study,published today in the ... in patients with permanent atrial fibrillation, that ... rate, on top of,other rate control agents. ... beats per,minute (p< 0, 0001) with dronedarone ...
... Landmark ARB trial investigated Micardis(R) (telmisartan) against ... endpoint of cardiovascular death, myocardial, infarction, stroke ... ACE, inhibitor intolerant high-risk patients receiving current ... 31 The primary results of the,TRANSCEND(TM)* ...
Cached Medicine Technology:American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation 2American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation 3TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 2TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 3TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 4TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 5TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 6TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 7
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: